COMPANY PROFILE

Forward Therapeutics

Explore full profile

Providing a platform for people to share their stories

Palm Beach Gardens, United StatesFounded 2022Biotech & Life Sciences

Valuation $100–500M Latest valuation · 2023

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Forward Therapeutics

Forward Therapeutics is a biopharmaceutical company focused on revolutionizing the treatment of chronic inflammatory disorders. The company is advancing a pipeline of novel, next-generation small molecule immune therapies aimed at expanding patient access to cutting-edge treatment options. Forward Therapeutics primarily serves patients suffering from chronic inflammatory conditions, working within the biopharmaceutical market. The business model is centered around research and development of proprietary therapies, which are then brought to market through clinical trials and regulatory approvals. Revenue is generated through the commercialization of these therapies, either directly or through partnerships with larger pharmaceutical companies. The company is led by experienced professionals with a strong track record in drug discovery and development.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2022
Headquarters: Palm Beach Gardens, United States
Employees: 12
Open positions: None listed
Dealroom signal: 48.1/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Latest news

Press, funding announcements and product moves mentioning Forward Therapeutics.

See all news

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES AOther financing	Nov 2023	$50M	$200M	RA Capital Management · BVF Partners · OrbiMed	↗
SEEDOther financing	Apr 2022	$0	—	Undisclosed	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Forward Therapeutics website traffic

Latest recorded traffic for Forward Therapeutics is 1.8K monthly website visits, up 28.6% over the last three months. Forward Therapeutics's team grew 0% over the past year.

Latest monthly visits1.8K 3-month web change+28.6% 1-year team growth0%

Monthly website visitsJun 2023–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ABAiolos BioRevolutionizing the treatment landscape for respiratory disease and other immune conditions	San Francisco, United States	Acquired	3	$245M	$1B
ZDZoo Pharma DynamicsInnovative animal healthcare solutions through advanced research and development	San Antonio, United States	Operational
ALAlderley Lighthouse LabsClinically led laboratory pathology and diagnostic testing services	Macclesfield, United Kingdom	Operational
NKNK:IODeveloping technologies to improve cancer treatment	London, United Kingdom	Operational
OCOne CuregenDeveloping diverse technologies necessary for the development of first-in-class global anticancer drugs	Daejeon, South Korea	Operational
LTLirum TherapeuticsClinical-stage targeted therapies for oncology and autoimmune diseases	New York City, United States	Operational
NBNormax BiomedNormax focus for 2022 is rapid growth in mRNA Vaccine R&D and manufacturing for sustainable pandemic preparedness	Cork, Ireland	Operational
NENENTEREngages in producing, developing, and selling medical intermediates	Jingzhou, China	Acquired